sellModerate cluster of 3
Chapman Rowan E sold $301k of NTRA
director at Natera, Inc.. 1,767 shares at an average of $170.24, traded Dec 10, 2024, filed Dec 11, 2024.
Warning score
49Value
$301k
1,767 shares
Holdings after
6,202
-22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-029037, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 10, 2024 | SOpen-market sale Common Stock | -1,767 | $170.24 | $301k | 6,202 | Dec 11, 2024 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 18Weak | sell 210b5-1 | NTRA Natera, Inc. | Fesko John PRESIDENT, CHIEF BUS. OFFICER | $107k | 669 | |
| 48Moderate | sell 2 | NTRA Natera, Inc. | BOTHA ROELOF director | $15M | 87,473 | |
| 33Weak | sell 210b5-1 | NTRA Natera, Inc. | Baynes Roy D. director | $5.4M | 37,230 | |
| 34Weak | sell 210b5-1 | NTRA Natera, Inc. | Chapman Steven Leonard CEO AND PRESIDENT | $692k | 4,728 | |
| 30Weak | sell 310b5-1 | NTRA Natera, Inc. | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | $236k | 1,866 | |
| 30Weak | sell 310b5-1 | NTRA Natera, Inc. | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | $237k | 1,992 | |
| 37Weak | sell 310b5-1 | NTRA Natera, Inc. | Chapman Steven Leonard CEO AND PRESIDENT | $468k | 3,960 | |
| 25Weak | sell 310b5-1 | NTRA Natera, Inc. | Fesko John PRESIDENT, CHIEF BUS. OFFICER | $110k | 929 | |
| 29Weak | sell 310b5-1 | NTRA Natera, Inc. | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | $191k | 1,605 | |
| 9Weak | sell 310b5-1 | NTRA Natera, Inc. | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | $59k | 496 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.